【盘前三分钟】11月3日ETF早知道

Core Insights - The article discusses the performance of various sectors and ETFs, highlighting the recent surge in the innovative pharmaceutical sector and the food and beverage industry, driven by favorable policies and strong company performances [1][5]. Sector Performance - The innovative pharmaceutical sector saw a significant increase, with the Hong Kong Stock Connect Innovative Drug Index rising over 5% on October 31, 2025, following the introduction of a new "commercial insurance innovative drug directory" mechanism [5][6]. - The food and beverage sector also experienced a rebound, with the CSI Food and Beverage Index closing up 1% on October 31, 2025, indicating a positive trend in consumer staples as fiscal and monetary policies align to support recovery [5][7]. Fund Flows - The top three sectors for capital inflow included media (3.058 billion), pharmaceuticals (1.971 billion), and utilities (0.564 billion) [2]. - Conversely, the sectors with the highest capital outflows were electronics (-18.309 billion), telecommunications (-9.437 billion), and power equipment (-6.815 billion) [2]. ETF Performance - The article lists several ETFs with notable performance, including the Hong Kong Stock Connect Innovative Drug ETF, which has shown a 4.84% increase over the past six months [3]. - The Food ETF and Medical ETF also demonstrated varying performance metrics, with the Food ETF showing a near flat performance over six months, while the Medical ETF had a significant increase of 16.68% [3][7]. Market Sentiment - The overall market sentiment is cautiously optimistic, with analysts suggesting that the innovative pharmaceutical sector is in a high-probability zone for medium to long-term investment due to controlled risks and strong performances from leading companies [5][6]. - The food and beverage sector is expected to recover from its cyclical low, supported by strong performance from leading companies and favorable economic conditions [5][7].